Delivery Order SPE2DB22D1103-SPE2DB23FE3VJ
Award Date 5/4/23
Potential Completion Date 5/5/23
Potential Value $6.9K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of NARCAN 4 MG NASAL SPRAY 2S for the Defense Logistics Agency (DLA). The contract has a ceiling value of $8,285.98 and an ultimate completion date of May 23, 2024. It is a firm fixed-price delivery order contract with no set-aside requirements. Amerisourcebergen Drug Corp is the prime contractor, and this award is part of a larger Indefinite Delivery Contract (IDC) valued at...
- This is a $2,530.77 firm fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) to provide NARCAN 4 MG NASAL SPRAY 2S. The contract has a performance period through July 7, 2025 and is not set aside. Amerisourcebergen also holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, allowing the company to supply a wide range of pharmaceutical products...
- The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $5,761.76 firm fixed price delivery order contract to supply NARCAN 4 MG NASAL SPRAY 2S. This delivery order is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 held by Amerisourcebergen Drug Corp, which serves as the primary contract vehicle for the company to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of NARCAN 4 MG NASAL SPRAY 2S. The contract, valued at $3,456.03, is a Firm Fixed Price Delivery Order with a period of performance through February 28, 2024. This contract is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of NARCAN 4 MG NASAL SPRAY. The contract has a firm fixed price of $1,050.48 and an ultimate completion date of July 9, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical division, which serves as the primary vehicle for...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NARCAN 4 MG NASAL SPRAY 2S, with a ceiling value of $1,177.41 and a completion date of May 19, 2025. The contract is a Firm Fixed Price type with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,016,532 units of NARCAN 4 mg nasal spray. The contract, valued at $7,151.88, has a period of performance through March 20, 2024. Amerisourcebergen Drug Corp is the prime contractor on this order, which is part of a larger indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00 and with a...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $1,982.29 for the supply of NARCAN 4 MG NASAL SPRAY 2S. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of May 16, 2024. The contract is a firm fixed-price Indefinite Delivery Contract (IDC) valued at $999,999,999, which serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of NARCAN 4 MG NASAL SPRAY 2S. The contract is a Delivery Order with a Firm Fixed Price pricing type and a ceiling value of $1,546.14. The contract has an ultimate completion date of July 16, 2024. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00...
- This federal contract award, valued at $5,486.40, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract provides for the delivery of NARCAN 4 MG NASAL SPRAY 2S, a critical medication used for the treatment of opioid overdose. The contract is structured as a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA...